Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Status:
Completed
Trial end date:
2019-10-16
Target enrollment:
Participant gender:
Summary
To determine the MTD/RP2D of the HDM201 and LEE011 combination and evaluate whether the
combination is safe and has beneficial effects in patients with liposarcoma.